JPRN-UMIN000013719已完成未知
Coronary intervention and optimal AntiPlatelet Therapy-Optical coherence tomography study- - CAPTO study
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with cardiovascular shock 2) Patients with a history of stent thrombosis 3) Patients who is impossible to be followed up at our institute 4) Patients scheduled to have PCI or bypass surgery 5) Patients who are treated with thienopyridine for secondary prevention of cerebrovascular event 6) Pregnant or possibly pregnant 7) Life expectancy <1 year 8) Patients after PCI 9) Patients who were judged inappropriate by the principal investigator
研究者
相似试验
已完成
不适用
Optimum platelet inhibition after coronary artery bypass surgery: a prospective, randomised trial comparing platelet aggregation using low- and medium-dose aspirin and clopidogrelCoronary artery bypass grafting (CABG)SurgeryISRCTN55334531Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)108
进行中（未招募）
1 期
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryStable coronary artery disease.MedDRA version: 17.0 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disordersEUCTR2014-000952-26-GBniversity of Edinburgh202
尚未招募
不适用
Assessing Optimal percutaneous coronary Intervention for LMCA RegistryJPRN-UMIN000014706Kyoto University2,000
尚未招募
不适用
Tailored versus Conventional Antiplatelet Strategy intended After Optimized Drug Eluting StentDiseases of the circulatory systemKCT0007408Asan Medical Center3,944
已完成
4 期
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 PolymorphismMyocardial InfarctionNCT00915733Gyeongsang National University Hospital80